RKDA

Arcadia Biosciences

Stock NASDAQ – Stock Market Prices, News & Analysis

Arcadia Biosciences is a biotechnology company that develops innovative agricultural crops through genetic modification to improve the nutritional quality and sustainability of agricultural products.

$ 1.32
1.49 %

Arcadia Biosciences

$ 1.32
1.49 %
RKDA

Arcadia Biosciences is a biotechnology company that develops innovative agricultural crops through genetic modification to improve the nutritional quality and sustainability of agricultural products.

Price history of Arcadia Biosciences
Price history of Arcadia Biosciences

Performance & Momentum

6 Months 60.65 %
1 Year 52.24 %
3 Years 81.16 %
5 Years 98.74 %

Strategic Analysis

Arcadia Biosciences • 2026

Arcadia Biosciences positions itself as a niche player in agricultural biotechnology, focusing on the development of genetically modified crops aimed at improving nutritional quality and sustainability. Its model is based on biotechnological innovation serving sustainable agriculture, responding to a growing demand for advanced and responsible agricultural solutions.

Strengths
  • Expertise in the intersection of biotech and sustainable agriculture
  • Innovation focused on improving the nutritional quality of crops
  • Positioning aligned with global environmental challenges
Weaknesses
  • Structurally weak stock performance over the long term
  • Lack of recent catalysts or positive news
Momentum

The current momentum is very weak with a pronounced downward trend over several years, reflecting a lack of market confidence and absence of positive impulses. This dynamic calls for caution, especially for investors seeking short or medium-term recoveries.

Similar stocks to Arcadia Biosciences

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone